drugset / Trial / NCT01306773
Convalescent Plasma Treatment in Severe 2009 H1N1 Infection
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Treatment of severe 2009 H1N1 infection with convalescent plasma will reduce mortality.
Timeline
- Start
- 2009-12
- Primary completion
- 2010-12
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Convalescent Plasma | Protein / enzyme biologic | 500 ml | — |
| Comparator | Oseltamivir | Small molecule | 75 mg | Oral |